KB
LH icon

Kimelman & Baird’s Labcorp LH Stock Holding History

Kimelman & Baird’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,746
Closed -$269K – 109
2018
Q2 		$269K Buy
+1,746
New +$264K 0.04% 95
2017
Q4 		$479K Hold
3,492
– – 0.07% 82
2017
Q3 		$453K Hold
3,492
– – 0.07% 83
2017
Q2 		$462K Hold
3,492
– – 0.07% 85
2017
Q1 		$430K Hold
3,492
– – 0.07% 85
2016
Q4 		$385K Buy
+3,492
New +$388K 0.06% 84

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kimelman & Baird's LH Position: Q3 2018 in Review

Kimelman & Baird sold out of Labcorp (LH) in Q3 2018, closing a stake of 1,746 shares — an estimated $269K sold.

Kimelman & Baird first reported a position in LH in Q4 2016 and held it in 6 quarters. The position peaked at $479K in Q4 2017. 794 funds tracked by Wall St. Rank hold LH as of Q3 2018.

  • Kimelman & Baird reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
  • Kimelman & Baird sold 1,746 Labcorp shares in Q3 2018, an estimated $269K.
  • Kimelman & Baird first reported a position in Labcorp in Q4 2016 and held it in 6 quarters.
  • Kimelman & Baird's Labcorp position peaked at $479K in Q4 2017.
  • 794 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Kimelman & Baird's 13F filing for Q3 2018, filed 30 Jan 2019.